Norma Beauchamp

Independent Director at Aurora Cannabis

Former CEO, Cystic Fibrosis Canada.

Norma Beauchamp was appointed a director of the Company on July 25, 2018, and is serving as Chair of the Nominating and Corporate Governance Committee. She is also a director of Acerus Pharmaceuticals Corporation, Chair of their Corporate Governance and Nominating committee and a member of their Audit committee. Formerly, Ms. Beauchamp was a director, Chair of the Corporate Governance and Compensation committees and a member of the Audit Committee of MedReleaf, and Chief Executive Officer of Cystic Fibrosis Canada. Ms. Beauchamp brings over three decades of experience in the corporate and non-profit sectors to her role having held senior leadership positions in Canada and Germany, including executive positions at Bayer and Sanofi. Ms. Beauchamp has served on the Boards of St. Joseph’s Health Centre Foundation, Providence Healthcare Foundation and the Breast Cancer Society of Canada. Throughout her career, she has been a patient advocate, working with patient and healthcare organizations to enhance access to care. Ms. Beauchamp has completed the University of Toronto’s Rotman School of Management Directors Education Program (ICD.D), and holds a Bachelor of Business Administration in Marketing from Bishop’s University.

Committees: Chair, Nominating & Governance

Other board appointments:

- Acerus Pharmaceuticals Corporation (2015 - )

- MedReleaf Corp. (2017 - 2018)

Timeline

  • Independent Director

    July, 2018 - present